Platform
Features
0 followers
Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel hydroxyl dendrimer (HD) therapeutics (HDTs) to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases.
Industries
Headquarters
Employees
Links
Jeffrey L. Cleland
6 members
2 members
Vaxcyte
2 followers
Kyverna Therapeutics
5 followers
Vizgen
1 follower
Chroma Medicine
EvolveImmune Therapeutics
Metagenomi
Thermo Fisher Scientific
143 followers
Genentech
144 followers
Gilead Sciences
121 followers
Biogen
108 followers
Regeneron
89 followers
Discover companies